Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neuroendocrine Tumors 3Gastro-enteropancreatic neuroendocrine tumor 3Adenoma, Islet Cell 2Recurrence 1Pancreatitis 1Pancreatic Intraductal Neoplasms 1Meningioma 1Fistula 1Duodenal Neoplasms 1Carcinoid Tumor 1Acromegaly 1

Interventions

tocotrienol, delta 1dehydroftorafur 1X-Rays 1Therapeutic Irrigation 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sulindac 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Phantoms, Imaging 1Pancreatectomy 1Octreotide 1Magnetic Resonance Spectroscopy 1Hydrocortisone 1Gemcitabine 1Fluorouracil 1Ferrosoferric Oxide 1Erlotinib Hydrochloride 1Drug Therapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Intraductal Neoplasms × Octreotide × 1 year × Clear all
NCT07262957 2025-12-22

PANENCA

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 4 Recruiting
400 enrolled
Gastrointestinal

Pancreatic Intraductal Neoplasms, Duodenal Neoplasms, Fistula, Pancreatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡